U S PHYSICAL THERAPY INC /NV Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables
U S PHYSICAL THERAPY INC /NV (USPH) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables of $2.60 million as of 2019-04-11, per its 10-K filed 2020-02-28.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill, Less Noncontrolling Interest › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) › Business Combination, Recognized Asset Acquired, Asset
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables · last filed 2021-03-01
- 2019-04-11: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables $2.60M.
- 2018-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables $1.69M.
- 2018-04-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables $1.63M; Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables as first filed $1.23M.
- 2017-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables $5.85M; Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables as first filed $6.25M.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables as first filed |
|---|---|---|
| 2019-04-11 | $2.60M 10-K · filed 2020-02-28 | |
| 2018-12-31 | $1.69M 10-K · filed 2019-03-18 | |
| 2018-04-30 | $1.63M 10-K · filed 2021-03-01 | $1.23M 10-Q · filed 2018-08-07 |
| 2017-12-31 | $5.85M 10-K · filed 2020-02-28 | $6.25M 10-K · filed 2018-03-14 |
| 2017-09-30 | $5.68M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $5.87M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $3.97M 10-Q · filed 2017-06-29 | |
| 2016-12-31 | $1.37M 10-K · filed 2019-03-18 | $1.71M 10-K · filed 2017-06-07 |
| 2016-02-29 | $1.06M 10-Q · filed 2016-11-04 | $1.06M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $1.95M 10-K · filed 2018-03-14 | $2.15M 10-K · filed 2016-03-04 |
| 2015-09-30 | $1.40M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $1.20M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $652.00K 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $1.21M 10-K · filed 2017-06-07 | $1.31M 10-K · filed 2015-03-12 |
| 2014-09-30 | $1.27M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $1.20M 10-Q · filed 2014-08-07 | |
| 2013-12-31 | $3.18M 10-K · filed 2016-03-04 | $3.90M 10-K · filed 2014-03-11 |
| 2013-02-28 | $1.34M 10-Q · filed 2013-11-07 | $1.35M 10-Q · filed 2013-08-08 |
| 2012-12-31 | $410.00K 10-K · filed 2015-03-12 | $363.00K 10-Q · filed 2013-08-08 |
| 2011-07-31 | $1.34M 10-K · filed 2014-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |